Results 191 to 200 of about 323,501 (341)

[Urinary excretion of antinuclear factors in systemic lupus erythematosus].

, 1967
Toshihiko Nagasawa, Seiichi Shibata
openalex   +3 more sources

Mimickers of Systemic Lupus Erythematosus: Case Series and Literature Overview. [PDF]

J Clin Med
Roest KL, Hak ALE, van Leeuwen EMM, de Bree GJ, Kwakernaak AJ.   +4 more
europepmc   +1 more source

Appearance of Hodgkin's disease in a patient with systemic lupus erythematosus

, 1967
Laurance B. Nilsen, Morris E. Missal, John J. Condemi   +2 more
openalex   +1 more source

Acute Renal Failure in Systemic Lupus Erythematosus [PDF]

, 1974
Claudio Ponticelli, E Imbasciati, Diego Brancaccio, A. Tarantino, E. Rivolta   +4 more
openalex   +1 more source

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

, 2020
Bathon, J., Breedveld, F., Burmester, G., Bykerk, V., Crofford, L., Cronstein, B., Dougados, M., Furst, D., Kalden, J., Mariette, X., Mease, P., Melchers, F., Rosenbaum, J., Sieper, J., Smolen, J., Weinblatt, M., Winthrop, K.   +16 more
core   +1 more source

Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy

Clinical Pharmacology &Therapeutics, EarlyView.
Hydralazine is a vasodilator typically used in the treatment of resistant hypertension and heart failure. N‐acetyltransferase 2 (NAT2) catalyzes the metabolism of hydralazine into inactive metabolites. NAT2 poor metabolizers (historically referred to as “slow acetylators”) are predicted to have increased plasma hydralazine concentrations compared with ...
Michael T. Eadon, David W. Hein, Michael A. Andersen, Arlene B. Chapman, Rhonda M. Cooper‐DeHoff, Zeruesenay Desta, Julio D. Duarte, Amanda L. Elchynski, Andrea Gaedigk, Seth E. Karol, Nita A. Limdi, Christelle Lteif, Laura Sosinski, Pablo Zubiaur, Michelle Whirl‐Carrillo, Teri E. Klein, Kelly E. Caudle, Roseann S. Donnelly, José A.G. Agúndez   +18 more
wiley   +1 more source

Unveiling Molecular Mechanisms Underlying Obesity-Associated Systemic Lupus Erythematosus. [PDF]

Endocrinol Diabetes Metab
Pillai RK, Pillai RK, Rajakumari Illankovan V, Balasubramaniam V, Alabsi AM, Biswas A, Darnal HK, Kayarohanam S, Janakiram MKS, Subramaniyan V.   +9 more
europepmc   +1 more source

Foundational Principles for the Quantitative Translation of T‐Cell Therapeutics for Hematologic Malignancies and Immunology

Clinical Pharmacology &Therapeutics, EarlyView.
T‐cell engaging antibodies (TCEs) and chimeric antigen receptor (CAR) T cells (CAR‐T cells) are among precision medicine therapies that have revolutionized the treatment of hematologic cancers. Their success in oncology has piqued interest in translating this promise into additional indications, such as autoimmune disorders.
Peter Ashcroft, Sarah McFann, Alex Ferguson, Arthur Van De Vyver, Suzanne Gaudet, Eshita Khera, Jan‐Frederik Schlender   +6 more
wiley   +1 more source

Cutaneous mucormycosis in systemic lupus erythematosus: a case report. [PDF]

Front Immunol
Li S, Meng T, Lin Y, Xie D, Li Z, Jiang Q.   +5 more
europepmc   +1 more source

Use of Enzyme-Linked Antibodies to Measure Serum Anti-DNA Antibody in Systemic Lupus Erythematosus [PDF]

, 1974
A J Pesce, Nina Mendoza, I. Boreisha, Marie Gaizutis, Victor E. Pollak   +4 more
openalex   +1 more source